Hogy MedicalLtd Valuation

Is 3593 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3593 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3593 (¥4615) is trading above our estimate of fair value (¥2512.95)

Significantly Below Fair Value: 3593 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3593?

Key metric: As 3593 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 3593. This is calculated by dividing 3593's market cap by their current earnings.
What is 3593's PE Ratio?
PE Ratio33.9x
EarningsJP¥2.94b
Market CapJP¥99.50b

Price to Earnings Ratio vs Peers

How does 3593's PE Ratio compare to its peers?

The above table shows the PE ratio for 3593 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.1x
7780 Menicon
24.4x17.7%JP¥117.9b
4549 Eiken Chemical
31.3x13.5%JP¥72.8b
7447 Nagaileben
24.3x4.2%JP¥68.5b
7979 Shofu
16.5x7.7%JP¥73.5b
3593 Hogy MedicalLtd
33.9x9.5%JP¥99.5b

Price-To-Earnings vs Peers: 3593 is expensive based on its Price-To-Earnings Ratio (33.9x) compared to the peer average (24.1x).


Price to Earnings Ratio vs Industry

How does 3593's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
3593 33.9xIndustry Avg. 14.3xNo. of Companies6PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 3593 is expensive based on its Price-To-Earnings Ratio (33.9x) compared to the JP Medical Equipment industry average (14.3x).


Price to Earnings Ratio vs Fair Ratio

What is 3593's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3593 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio33.9x
Fair PE Ratio17.5x

Price-To-Earnings vs Fair Ratio: 3593 is expensive based on its Price-To-Earnings Ratio (33.9x) compared to the estimated Fair Price-To-Earnings Ratio (17.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3593 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥4,615.00
JP¥4,016.67
-13.0%
7.9%JP¥4,450.00JP¥3,700.00n/a3
Nov ’25JP¥4,515.00
JP¥4,016.67
-11.0%
7.9%JP¥4,450.00JP¥3,700.00n/a3
Oct ’25JP¥4,680.00
JP¥4,040.00
-13.7%
11.6%JP¥4,670.00JP¥3,550.00n/a3
Sep ’25JP¥4,425.00
JP¥4,040.00
-8.7%
11.6%JP¥4,670.00JP¥3,550.00n/a3
Aug ’25JP¥4,035.00
JP¥4,040.00
+0.1%
11.6%JP¥4,670.00JP¥3,550.00n/a3
Jul ’25JP¥3,970.00
JP¥3,810.00
-4.0%
7.0%JP¥4,080.00JP¥3,450.00n/a3
Jun ’25JP¥3,955.00
JP¥3,810.00
-3.7%
7.0%JP¥4,080.00JP¥3,450.00n/a3
May ’25JP¥3,760.00
JP¥3,710.00
-1.3%
7.2%JP¥4,080.00JP¥3,450.00n/a3
Apr ’25JP¥3,725.00
JP¥3,656.67
-1.8%
4.3%JP¥3,870.00JP¥3,500.00n/a3
Mar ’25JP¥3,630.00
JP¥3,540.00
-2.5%
8.4%JP¥3,870.00JP¥3,150.00n/a3
Feb ’25JP¥3,550.00
JP¥3,540.00
-0.3%
8.4%JP¥3,870.00JP¥3,150.00n/a3
Jan ’25JP¥3,615.00
JP¥3,510.00
-2.9%
7.5%JP¥3,780.00JP¥3,150.00n/a3
Dec ’24JP¥3,475.00
JP¥3,510.00
+1.0%
7.5%JP¥3,780.00JP¥3,150.00n/a3
Nov ’24JP¥3,290.00
JP¥3,510.00
+6.7%
7.5%JP¥3,780.00JP¥3,150.00JP¥4,515.003
Oct ’24JP¥3,195.00
JP¥3,540.00
+10.8%
8.4%JP¥3,870.00JP¥3,150.00JP¥4,680.003
Sep ’24JP¥3,215.00
JP¥3,375.00
+5.0%
6.7%JP¥3,600.00JP¥3,150.00JP¥4,425.002
Aug ’24JP¥3,115.00
JP¥3,375.00
+8.3%
6.7%JP¥3,600.00JP¥3,150.00JP¥4,035.002
Jul ’24JP¥3,175.00
JP¥3,555.00
+12.0%
11.0%JP¥4,170.00JP¥3,150.00JP¥3,970.004
Jun ’24JP¥3,185.00
JP¥3,555.00
+11.6%
11.0%JP¥4,170.00JP¥3,150.00JP¥3,955.004
May ’24JP¥3,370.00
JP¥3,555.00
+5.5%
11.0%JP¥4,170.00JP¥3,150.00JP¥3,760.004
Apr ’24JP¥3,175.00
JP¥3,580.00
+12.8%
11.1%JP¥4,170.00JP¥3,050.00JP¥3,725.004
Mar ’24JP¥3,195.00
JP¥3,580.00
+12.1%
11.1%JP¥4,170.00JP¥3,050.00JP¥3,630.004
Feb ’24JP¥3,255.00
JP¥3,580.00
+10.0%
11.1%JP¥4,170.00JP¥3,050.00JP¥3,550.004
Jan ’24JP¥3,410.00
JP¥3,323.33
-2.5%
13.2%JP¥3,870.00JP¥2,800.00JP¥3,615.003
Dec ’23JP¥3,480.00
JP¥3,323.33
-4.5%
13.2%JP¥3,870.00JP¥2,800.00JP¥3,475.003
Nov ’23JP¥3,285.00
JP¥3,265.00
-0.6%
12.0%JP¥3,870.00JP¥2,800.00JP¥3,290.004

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies